ETON
Eton Pharmaceuticals Inc
54.80$
-1.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.4% | 5.3% | -31.0% | 13.8% | 28.6% | -6.6% | 12.1% | 42.0% | 53.5% | -54.3% | 30.5% | 19.3% | 14.3% | |
| 2.9% | 3.8% | 2.9% | 2.9% | 2.7% | 3.0% | 5.9% | 5.3% | 4.5% | 4.8% | 4.7% | 3.7% | 4.3% | |
| 10.4% | 10.3% | 10.3% | 9.3% | 7.0% | 6.7% | 6.9% | 11.1% | 4.9% | 5.3% | 6.3% | 3.9% | 4.9% | |
| 7.0% | 21.8% | -34.6% | 34.6% | 12.5% | -20.3% | 0.0% | 32.6% | 46.1% | -81.6% | 10.3% | -16.2% | -10.1% | |
| 0.0% | 10.6% | 23.6% | 0.0% | 18.1% | 0.1% | 0.0% | 0.0% | 1.3% | 0.2% | 0.3% | 0.0% | 0.4% | |
| – | -10.6% | -23.6% | – | 18.1% | -327.4% | – | – | -1.3% | -0.2% | -62.1% | 0.0% | -14.6% | |
| – | -1.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -3.7% | 217.3% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | |
| -5.2% | -4.0% | -4.7% | -2.4% | -3.7% | 288.2% | 2.3% | 0.0% | 0.0% | 2.0% | 5.7% | -0.2% | 1.6% | |
| 7.2% | -9.3% | -59.4% | 11.5% | 24.9% | -45.7% | 14.4% | 42.0% | 52.3% | -52.5% | -25.9% | 19.1% | 1.4% | |
| 12.4% | -5.3% | -54.7% | 13.8% | 28.6% | -6.7% | 12.1% | 42.0% | 52.3% | -54.5% | 30.2% | 19.3% | 14.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.